Thompson Investment Management’s Zimmer Biomet ZBH Stock Holding History

Thompson Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.04K	Hold	35	–	–	﹤0.01%	462
2026 Q1	$3.2K	Hold	35	–	–	﹤0.01%	447
2025 Q4	$3.18K	Hold	35	–	–	﹤0.01%	454
2025 Q3	$3.48K	Hold	35	–	–	﹤0.01%	442
2025 Q2	$3.23K	Hold	35	–	–	﹤0.01%	438
2025 Q1	$4K	Hold	35	–	–	﹤0.01%	421
2024 Q4	$3.73K	Hold	35	–	–	﹤0.01%	433
2024 Q3	$3.8K	Hold	35	–	–	﹤0.01%	421
2024 Q2	$3.81K	Hold	35	–	–	﹤0.01%	421
2024 Q1	$4.63K	Hold	35	–	–	﹤0.01%	429
2023 Q4	$4.26K	Hold	35	–	–	﹤0.01%	365
2023 Q3	$3.93K	Hold	35	–	–	﹤0.01%	358
2023 Q2	$5.1K	Hold	35	–	–	﹤0.01%	363
2023 Q1	$4.52K	Buy	+35	New	+$4.39K	﹤0.01%	361
2018 Q3	–	Sell	-40,618	Closed	-$4.39M	–	183
2018 Q2	$4.39M	Buy	40,618 +201	+0.5%	+$21.9K	0.8%	55
2018 Q1	$4.28M	Sell	40,417 -786	-2%	-$91.3K	0.8%	59
2017 Q4	$4.83M	Buy	41,203 +1,135	+3%	+$128K	0.85%	52
2017 Q3	$4.55M	Buy	40,068 +227	+0.6%	+$26.2K	0.85%	52
2017 Q2	$4.97M	Sell	39,841 -513	-1%	-$60.8K	0.93%	45
2017 Q1	$4.78M	Sell	40,354 -562	-1%	-$63.7K	0.91%	43
2016 Q4	$4.1M	Buy	40,916 +8,672	+27%	+$929K	0.8%	57
2016 Q3	$4.07M	Sell	32,244 -392	-1%	-$48.4K	0.78%	60
2016 Q2	$3.81M	Sell	32,636 -2,734	-8%	-$309K	0.78%	61
2016 Q1	$3.66M	Buy	35,370 +26	+0.1%	+$2.52K	0.77%	63
2015 Q4	$3.52M	Sell	35,344 -402	-1%	-$39.3K	0.73%	64
2015 Q3	$3.26M	Sell	35,746 -122	-0.3%	-$12.2K	0.7%	68
2015 Q2	$3.8M	Buy	35,868 +1,136	+3%	+$126K	0.73%	70
2015 Q1	$3.96M	Sell	34,732 -642	-2%	-$73.2K	0.75%	69
2014 Q4	$3.9M	Sell	35,374 -1,761	-5%	-$186K	0.74%	68
2014 Q3	$4.01M	Sell	37,135 -1,272	-3%	-$125K	0.77%	65
2014 Q2	$3.87M	Sell	38,407 -429	-1%	-$41.9K	0.75%	66
2014 Q1	$3.57M	Sell	38,836 -1,411	-4%	-$130K	0.71%	70
2013 Q4	$3.64M	Sell	40,247 -484	-1%	-$41.9K	0.72%	71
2013 Q3	$3.25M	Sell	40,731 -227	-0.6%	-$17.9K	0.7%	71
2013 Q2	$2.98M	Buy	+40,958	New	+$3.06M	0.69%	71

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Thompson Investment Management's ZBH Position: Q2 2026 in Review

Thompson Investment Management held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 35 shares worth $3.04K. The position accounts for ﹤0.01% of the portfolio, ranked #462.

Thompson Investment Management first reported a position in ZBH in Q2 2013 and has held it in 35 quarters since. The position peaked at $4.97M in Q2 2017. 115 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Thompson Investment Management held 35 shares of Zimmer Biomet worth $3.04K as of Q2 2026.
Thompson Investment Management left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up ﹤0.01% of Thompson Investment Management's portfolio in Q2 2026, its #462 holding.
Thompson Investment Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 35 quarters since.
Thompson Investment Management's Zimmer Biomet position peaked at $4.97M in Q2 2017.
115 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Thompson Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.